Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

KORU Medical Systems (KRMD) Operating Expenses (2020 - 2025)

KORU Medical Systems has reported Operating Expenses over the past 11 years, most recently at $7.4 million for Q4 2025.

  • Quarterly results put Operating Expenses at $7.4 million for Q4 2025, up 2.97% from a year ago — trailing twelve months through Dec 2025 was $28.6 million (up 2.87% YoY), and the annual figure for FY2025 was $28.6 million, up 2.87%.
  • Operating Expenses for Q4 2025 was $7.4 million at KORU Medical Systems, up from $7.1 million in the prior quarter.
  • Over the last five years, Operating Expenses for KRMD hit a ceiling of $7.4 million in Q4 2025 and a floor of $4.6 million in Q2 2021.
  • Median Operating Expenses over the past 5 years was $6.8 million (2022), compared with a mean of $6.5 million.
  • Peak annual rise in Operating Expenses hit 71.73% in 2021, while the deepest fall reached 22.73% in 2021.
  • KORU Medical Systems' Operating Expenses stood at $5.9 million in 2021, then rose by 10.84% to $6.6 million in 2022, then decreased by 0.93% to $6.5 million in 2023, then rose by 9.56% to $7.2 million in 2024, then grew by 2.97% to $7.4 million in 2025.
  • The last three reported values for Operating Expenses were $7.4 million (Q4 2025), $7.1 million (Q3 2025), and $6.8 million (Q2 2025) per Business Quant data.